Trending

Sensitivity to dairy products, other foods linked to higher risk of death from heart disease
Medtronic gains 2 key approvals for its ablation portfolio
Deep learning in cardiovascular imaging: 4 key takeaways for cardiologists
Smartphone app helps TAVR patients avoid major complications
FDA clears AI-powered image reconstruction technology for cardiac CT scanners
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.
New formula could mean diabetes and weight loss drugs such as semaglutide are only needed every 4 months

GLP-1 agonists are often taken as daily or weekly injections. A new delivery system could help make it so those same drugs are only required three times per year. 

Cardiawave Valvosoft non-invasive ultrasound therapy
Cardiawave’s non-invasive ultrasound therapy impresses cardiologists early on—could it be an alternative to SAVR, TAVR?

While TAVR and SAVR are reliable treatments for calcific aortic stenosis, some patients are not considered for those procedures due to severe comorbidities or a limited life expectancy. This is where the investigational Valvosoft device from Cardiawave enters the equation.

Medtronic Penditure Left Atrial Appendage (LAA) Exclusion System
Medtronic debuts new FDA-cleared LAA exclusion device

Medtronic acquired the technology behind the new device back in August.

the words "FDA recall" on a board
FDA announces recall of infusion sets due to defect that puts diabetes patients at risk

The FDA considers this a Class I recall, which means using the impacted devices “may cause serious injuries or death.” One patient injury has been reported at this time. 

Mediterranean diet
Mediterranean diet improves cardiovascular health of middle-aged women

Following the popular Mediterranean diet instead of a “Western” diet can be quite beneficial for women in their forties and fifties, researchers confirmed. 

Stop
Bayer ends blood thinner trial early due to lack of efficacy

The Independent Data Monitoring Committee recommended Bayer stop the trial due to the drug's poor performance compared to apixaban. 

Pills
ADHD medications associated with heightened CVD risk

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

Around the web

Radiology Business
Radiologists grab much smaller share than cardiologists of burgeoning interventional market

Endovascular procedure volumes surged 427% among cardiologists between 2010-2018, compared to a 125% uptick among radiologists. 

Health Imaging
Technology that creates interactive holograms of the heart cleared by FDA

SentiAR's CommandEP interface facilitates 3D models of the heart, made possible through augmented reality. 

COVID-19

American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
CVD deaths have increased dramatically, undoing years of progress
Cardiologist reprimanded for performing surgery after testing positive for COVID-19
Hospitals still struggling to reach pre-COVID heart attack care thresholds due to pandemic disruption
MORE »

Heart Failure

Barostim Neo 2 CVRx heart failure nerve stimulator on display at HRS 2023. Photo by Dave Fornell
CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure
A closer look at how weight loss drug semaglutide improves the cardiovascular health of obese patients without diabetes
The future of cardiology: 5 potentially game-changing AI studies from AHA 2023
CMS increases reimbursement for AI-powered heart failure platform
CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure
MORE »

Heart Rhythm

Medtronic's PulseSelect Pulsed Field Ablation (PFA) System
Medtronic gains 2 key approvals for its ablation portfolio
Bayer ends blood thinner trial early due to lack of efficacy
Medtronic gains 2 key approvals for its ablation portfolio
The future of cardiology: 5 potentially game-changing AI studies from AHA 2023
10 ways to improve care for in-hospital cardiac arrest
MORE »
Design by Adaptive Theme